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ABSTRACT  
Ligand-mediated targeting and internalization of plasma membrane receptors is central to 
cellular function. These types of receptors have accordingly been investigated as targets to 
facilitate entry of diagnostic and therapeutic constructs into cells. However, there remains a 
need to characterize how receptor targeting agents on nanoparticles interact at surface receptors 
and whether it is possible to control these interactions via exogenous stimuli. Here, we describe 
the switchable display of the iron-transporting protein, transferrin (Tf), at the surface of 
thermoresponsive polymer-coated gold nanoparticles, and show that internalization of the 
coated nanoparticles into target cells changes across temperature ranges over which transferrin 
is expected to be sterically ‘hidden’ by an extended polymer chain and then ‘revealed’ by 
polymer chain collapse. The switching process is dependent on the numbers of transferrin 
molecules and thermoresponsive polymer chains attached, and whether the assay temperature 
is above or below the transition temperatures of the responsive polymers at the nanoparticle 
surfaces. Significantly, however, the control of internalization is critically reliant on overall 
nanoparticle colloidal stability while the thermoresponsive component of the surface undergoes 
conformational change. The data show that the cell entry function of complex and large 
biomolecule ligands can be modulated by polymer-induced accessibility change, but that a 
simple ‘hide and reveal’ mechanism for ligand display following polymer chain collapse is 
insufficient to account for nanoparticle uptake and subsequent intracellular trafficking. 
 
Introduction 
Polymer-metal hybrid nanoparticles offer many advantages for diagnosis and therapy, owing 
to the possibility to endow these materials with multiple functionalities for detecting disease, 
releasing therapeutic agents or treat the pathology by enhancing externally applied physical 
stimuli.1-6 However, the clinical applications of nanoparticles in general have been limited by 
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complex and unpredictable pharmacokinetics and targeting.7-10 In order to achieve maximal 
clinical response in vivo any diagnostic or therapeutic agent needs to accumulate at the target 
tissue and gain access to disease relevant cells and appropriate intracellular compartments. 
Even if a nanoparticle can successfully transit across in vivo barriers such as mucosal surfaces 
or plasma membranes, successful internalization at a specific desired cell requires spatial and 
temporal display of a functional signal, such as a ligand, to interact with a cellular receptor. 
Maintaining this ligand accessibility has proven to be challenging owing to the difficulties in 
ensuring that synthetic materials accurately display their functionality in complex biological 
environments.11-14  
Amongst the emerging sets of materials for therapeutic delivery and diagnostic applications 
in vivo are gold nanoparticles (AuNPs) and their derivatives.15-18 These systems are of 
significant interest because methods to modulate surface functionality, particle charge, 
topology, shape and size, as well as simple routes to multiple different surface chemistries, are 
very well-established for AuNPs. As a consequence, AuNPs are promising test-beds for 
probing structure-function relationships in biomedical settings, especially as key chemical 
parameters and material properties can be altered systematically in order to assess their effects 
on biological activity. Ligand display is particularly amenable to control at AuNP surfaces 
because of well-defined and robust conjugation approaches developed so far; in fact many ,-
heterobifunctional thiol reagents are commercially available, allowing strong covalent 
attachment in defined domains to the gold substrate and providing chemical handles to attach 
biological ligands. 
The range of ligands attached to AuNPs which have been used to influence cellular 
interactions includes small molecule agents, peptides, growth factor derivatives and proteins.12, 
19-23 High molecular weight ligands such as proteins offer high recognition selectivity with their 
cognate receptors under tightly-defined conditions and so are obvious candidates to target 
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AuNPs to specific receptors on cells of interest. The iron binding protein transferrin (Tf), has 
been extensively studied as a delivery vector for specific therapeutics which otherwise show 
limited cellular uptake.24-28 This is because transferrin plays an essential role in the transport 
of free iron into cells, its mechanism of uptake is well established, it is constitutively 
endocytosed and transferrin receptors (TfR) are overexpressed in a number of disease states. 
Tf-drug conjugates have been used to target solid tumors owing to the requirements of some 
cancer cells for high levels of iron. However, ligand-mediated endocytosis, as a single method 
of targeting, has limitations owing to the presence of receptors in healthy tissue, and this is a 
particular issue for Tf-based systems, as transferrin receptors are also highly expressed at the 
blood brain barrier.25 It would therefore be very desirable if it were possible to ‘hide’ ligands 
such as Tf from cognate receptors on healthy cells, but display the protein when in proximity 
to diseased tissue, thus controlling the functionality of Tf-targeted diagnostics and therapeutics 
to specific disease sites.  
Here we describe how Tf-mediated endocytosis can be switched by controlling the display 
of the protein at gold nanoparticle surfaces utilizing multicomponent polymer-transferrin gold 
nanoparticle conjugates. We synthesized gold particles functionalized with charge- and 
entropically-stabilizing zwitterionic hydrophilic polymers containing azide and thiol termini. 
Transferrin and thermoresponsive polymers were subsequently attached to the polymer-AuNP 
conjugate via dibenzocyclooctyne (DBCO) copper-free click chemistry. The physical 
properties of nanoparticles with a range of different Tf and thermoresponsive polymer grafting 
densities were measured and their effects on cellular transport evaluated. The AuNP polymer 
protein conjugates synthesized were colloidally stable over the time course of the cellular 
uptake experiments. Temperature-mediated uptake of the thermoresponsive AuNP Tf 
conjugates was achieved via selection and screening of different polymer and protein grafting 
densities. 
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Shielding of Tf via the chain-extended responsive polymers resulted in low levels of cell entry 
at 37 °C, whereas chain-collapse of polymers at temperatures relevant to clinically applied 
ultrasound and local tumour hyperthermia (39-41 °C),29 resulted in enhanced nanoparticle 
uptake. This demonstrated that a macromolecular ligand for a cell surface receptor could be 
‘switched on’ or ‘off’ by an external stimulus. In addition, confocal microscopy analysis of the 
multi-conjugate AuNPs in a cancer cell line demonstrated that transport occurred rapidly to 
lysosomal compartments. 
 
RESULTS  
Preparation of gold nanoparticles, polymers and polymer-protein-conjugates 
Gold nanoparticle protein polymer conjugates were prepared by successive synthesis and 
coupling of the individual gold, polymer and protein components. The first step involved 
anchoring an ATRP-type initiator (Compound 1, Figure 1a) derived from readily available 
lipoic acid, to gold nanoparticles, using the cyclic disulfide terminus from the lipoic acid to 
form strong bonds to the metal surface.   
 6 
 
Figure 1: Synthesis overview: a) Hydrophilic MPC-azide-TriEG-functional block-
copolymer for AuNP (lipoic acid ester) primary corona; b) Thiotransferrin DBCO conjugation 
and Alexa Fluor 488 labelling; c) Thermoresponsive PEGMA DBCO functionalized polymer. 
The co-monomer ratios in CP-1 were estimated from NMR spectra integrals and indicate actual 
content as opposed to estimates from co-monomer addition ratios. 
 
Gold nanoparticles were synthesized by in situ reduction of gold salts and characterized by 
TEM (Figure S1). Average diameters of the AuNPs were 25-30 nm (TEM) prior to polymer 
conjugation. From compound (1), a 2-methacryloyloxyethyl phosphorylcholine (MPC) 
homopolymer was initially grown. At high MPC conversion (DP ~92), 2-(2-(2-
azidoethoxy)ethoxy)ethyl methacrylate monomer (2, Azido-TriEG-Methacrylate) and an 
additional amount of the MPC monomer were added to form the final MPC-azide-TriEG block-
copolymer. NMR analysis of the purified resulting block-copolymer revealed that each MPC-
azide-TriEG copolymer contained an average of 3 azide functional side-chains.  
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Thio-transferrin, a Tf mutant with a free cysteine,29, 30 was used to synthesize the reactive 
alkyne DBCO Tf derivative (Figure 1b). DBCO–maleimide was added to the thio-transferrin 
in slight excess, resulting in Tf conjugation of 70% efficiency: increases in the molar equivalent 
of maleimide-DBCO linker to Tf did not improve the conjugation to thiol. The partially DBCO-
modified Tf proved difficult to purify at this stage, but was found to be suitable for subsequent 
coupling reactions since the unmodified protein was nonreactive towards the AuNP MPC-azide 
conjugates and was easily removed after nanoparticle conjugation. The DBCO-Tf conjugate 
was labelled with Alexa Fluor 488 (AF488) SDP to allow monitoring of nanoparticle uptake 
and localization of the transferrin-gold nanoparticle conjugates into cells.  Spectroscopic 
analysis after GPC removal of the free dye demonstrated that on average 2.7 dye molecules 
were linked to the DBCO-Tf.  
For thermal modulation of transferrin accessibility at the AuNP surfaces, we aimed to attach 
polymers based on thermoresponsive polyethylene glycol methacrylate (pPEGMA)30 to form 
a ‘reversibly shielding’ outermost layer. Accordingly, the pPEGMA materials were prepared 
from a disulfide bifunctional initiator (Figure 1c), with co-monomers chosen to control the 
onset of coil-to-globule transitions to around 37 C, and molar masses varied to modulate steric 
hindrance. The resultant disulfide-linked co-polymers were readily cleaved using TCEP to 
produce polymer chains with free thiol termini, which in turn were reacted with DBCO - 
maleimide and purified by Gel Permeation Chromatography (GPC) to afford an alkyne-
functional thermoresponsive polymer (coded TRP-1, Table 1), designed to react with the azide 
side-chains on the MPC- azido-TriEG co-polymers already attached to gold nanoparticle 
substrates. The cleavage of the disulfide bond in the ‘dimeric’ pPEGMA material and 
subsequent reaction of the pPEGMA-thiol terminus with DBCO-maleimide to form a reactive 
alkyne (TRP-1 Figure 1) were monitored by Ellman assays and GPC analysis to ensure 
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completion of reaction. The properties of the zwitterionic MPC ‘corona’ polymer (CP-1) and 
the thermoresponsive polymers (TRP-1 Figure 1) are shown in Table 1 and Figure S2 (ESI).  
 
Polymer Mn
a / kDa Mn / kDa GPC Mw/Mn Cloud point °C 
Azide-TriEG-MPC 31.7 26b 1.2 - 
TRP-1  
(pPEGMA-DBCO) 
27.9 25 c 1.6 39d 
Table 1: Polymer characteristics. a) Theoretical, calculated from monomer/initiator ratio and 
conversion. b) From GPC (DPBS, PEG standards); c) From GPC (CHCl3, polystyrene 
standards); d) measured at 1.25 mg.mL-1 in PBS.   
 
 
Synthesis and characterization of AuNP polymer-protein conjugates 
Functionalization of the AuNPs with the MPC-azide-polymer via the lipoic disulfide group 
occurred rapidly simply by mixing in aqueous solutions. Any unreacted polymer was removed 
by centrifugation of the nanoparticles and removal of the supernatant. Grafting density was 
determined by measuring residual non-conjugated MPC polymer in the supernatant; GPC 
analysis of this solution revealed that approximately 500 polymer chains were attached to each 
gold nanoparticle, in accord with similar grafting densities reported for AuNPs of similar sizes 
previously.31, 32 Particle recovery after repeated centrifugation and purification cycles was 
essentially quantitative, i.e. no macro particle aggregation, nor any shift in the UV absorption 
spectrum for the particles was observed. Centrifugal analysis of the polymer-functionalized 
gold nanoparticles showed decreased sedimentation speed in comparison to the unmodified 
gold nanoparticles (data not shown). The polymer functionalized gold nanoparticles were 
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stable in isotonic phosphate buffered saline and cell culture media while the unmodified gold 
nanoparticles aggregated rapidly in the presence of salt.  
Transferrin DBCO-AF488 conjugates were grafted onto the MPC-azide functionalized 
AuNPs to generate batches containing grafting ratios of 2, 4 or 8 transferrin equivalents. After 
reaction at 4°C with gentle agitation for three days, the resultant Tf-AuNP conjugates were 
repeatedly isolated by centrifugation and resuspension in buffer solutions until no free protein 
was detected in the supernatant. Particle concentrations were confirmed by UV-Vis 
spectroscopy and particle recovery was calculated by direct comparison to the initial stock 
AuNP MPC-azide solution. Protein grafting density was determined by comparing the AF488 
fluorescence in the initial supernatant to that of the protein AF488 stock. Recovery of the initial 
nanoparticle stock concentration ranged from 92.5% to 99% for all three batches.  
The DBCO-functionalized thermoresponsive polymer TRP-1 was grafted directly onto the 
three Tf-AuNP conjugates by adding large excesses (100 equivalents of TRP-1 with respect to 
azide groups on the NPs) for each AuNP per batch. The particulate suspensions were allowed 
to react for three days at 4°C. The unreacted polymers were then removed by centrifugation 
and grafting densities were determined by GPC polymer analysis of the initial supernatants. 
Centrifugation was repeated until no free polymer was detected in the supernatant. In contrast 
to the AuNPs with only the zwitterionic MPC-Tf outer surface, addition of the pPEGMA TRP-
1 layer caused a significant loss during the purification stages. In each batch around one third 
of the initial particle content was lost due to irreversible aggregation and adsorption onto the 
centrifugation tubes. GPC analysis of the supernatant from the batches of the AuNPs with 
varying Tf content revealed that thermoresponsive polymer grafting increased as the amount 
of transferrin on the surface of the particle decreased. For the batch of AuNP which had the 
lowest amount of transferrin attached, an average of 7 pPEGMA TRP-1 chains were conjugated 
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to each AuNP, while for the batch containing the highest amount of transferrin per AuNP only 
2 TRP-1 chains were coupled.  
The colloidal stability of the three Tf-AuNP batches with (pPEGMA-Tf-AuNP-1-3) and 
without (Tf-AuNP-1-3) the pPEGMA outer layer was tested at 37°C in cell culture medium to 
ensure the particles were stable over the time course of any subsequent cell uptake experiments 
(Figure S3). Without the pPEGMA corona no aggregation was observed for any of the Tf-
AuNP batches over the target time period of 4 h (intended cell culture assay time), while for 
all the pPEGMA conjugates a small decrease in the UV-Vis absorption (~15%) was observed 
over the same period.. Light scattering analysis of the nanoparticles in dilute phosphate buffer 
saline at 33 °C and pH 7.4 showed hydrodynamic diameters of 48-50 nm for the Tf-AuNPs and 
55-60 nm for the pPEGMA-AuNPs (Table S1: DLS data based on the number distributions). 
These sizes were larger than those recorded in TEM (Figure S2), as expected based on the 
normal drop in sizes recorded for hydrated materials when subject to vacuum dehydration as 
part of processing for TEM.  
Increase in temperature to 41°C, i.e. above the phase transition temperature of the responsive 
polymer coat for the pPEGMA-Tf-AuNPs, indicated that the particle size distributions were all 
shifted to higher diameter. Particles with diameters of 60-80 nm were present in all the samples, 
but also some much larger species (> 300 nm) were apparent in DLS at the higher temperatures, 
due most likely to protein induced particle association as well as hydrophobic interchain 
interactions of the pPEGMA grafts (Table S1). The pPEGMA-Tf-AuNP-1 and 2 samples were 
the most prone to aggregation of the responsive polymer coated materials, whereas pPEGMA-
Tf-AuNP-3 particles exhibited much less self-association above the pPEGMA coil-to-globule 
transition temperature. These differences in nanoparticle aggregation were most likely due to 
the numbers of pPEGMA chains on the respective nanoparticle outer surfaces, with pPEGMA-
Tf-AuNP-1 and 2 samples associating more rapidly with each other due to the presence of 
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larger hydrophobic domains on their surfaces above the pPEGMA coil-to-globule transition 
temperature compared to pPEGMA-Tf-AuNP-3   
Zeta potential measurements (Table S2) of the Tf-AuNPs and pPEGMA-Tf-AuNPs in dilute 
phosphate buffer revealed that the charges of all the particulate conjugates were negative (~ -6 
to -19 mV) across the temperature range tested (33-41°C). These zeta potentials were in line 
with expectation since Tf is negatively charged at physiological pH and the zwitterionic 
polymers were not anticipated to contribute to the overall charge. There was also a marked shift 
to more negative zeta potential with increasing temperature for all samples except pPEGMA-
Tf-AuNP-3, which was also the least negatively charged at the highest temperature, 41°C, 
which have been associated with buffer ion desorption at increased temperature.   
The properties of the AuNPs and their conjugates are provided in Table 2, with cartoon 
representations of their structures shown in Figure 2. 
 
 Code 
Number of 
Tf/AuNP 
Number of attached 
pPEGMA 
chains/AuNP) 
Mn of attached 
polymer / kDa 
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Tf-AuNP-1 0.7 0 - 
Tf-AuNP-2 1.3 0 - 
Tf-AuNP-3 3.0 0 - 
T
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o
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N
P
s 
pPEGMA-
Tf-AuNP-1 
0.7 6.8 25 
pPEGMA-
Tf-AuNP-2 
1.3 4.4 25 
pPEGMA-
Tf-AuNP-3 
3.0 2.2 25 
Table 2 Properties of Polymer Transferrin Gold nanoparticle conjugates.  
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Figure 2. Preparation route, cartoon representations and sample codes for functionalized gold 
nanoparticles and conjugates. Tf = transferrin, pPEGMA = 
poly(polyethyleneglycol)methacrylate), AuNP = gold nanoparticle. Tf-AuNP-1 and pPEGMA-
Tf-AuNP-1 have a mean of 0.7 Tf per nanoparticle, Au-Tf-NP-2 and pPEGMA-Tf-AuNP-2 
have a mean of 1.3 Tf per nanoparticle, and Au-Tf-NP-3 and pPEGMA-Tf-AuNP-3 have a 
mean of 3.0 Tf per nanoparticle 
 
Biorecognition properties of AuNP polymer-protein conjugates 
Surface plasmon resonance (SPR) analysis of the three batches with and without pPEGMA 
coatings was carried out on an SPR functionalized transferrin receptor (TfR) chip at 25°C and 
37°C (Figure S4). These temperatures were chosen to be well below (25°C) and at the point of 
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onset of the polymer phase transitions (37-39 °C). Control samples of pMPC-AuNP, i.e. the 
nanoparticles with the passivating poly(zwitterionic) layer but without transferrin or responsive 
polymer corona were used to evaluate non-specific surface attachment for the SPR 
measurements. The observed SPR response increased with temperature and with the number 
of transferrin molecules per AuNP (Figure S4). The addition of the pPEGMA chains to the Tf-
AuNP surfaces augmented the binding of the particles to the TfR-functionalised surfaces both 
at 25°C and 37°C for the pPEGMA-Tf-AuNP-2 (1.3 Tf and 4.4 pPEGMA chains per NP) and 
pPEGMA-Tf-AuNP-3 (3.0 Tf and 2.2 pPEGMA chains per NP) but decreased with 
temperature for pPEGMA-AuNP-1 (0.7 Tf and 6.8 pPEGMA per NP). These data (Table 2 and 
Figure S4) suggested that at the lower Tf content and higher pPEGMA levels, the protein on 
NPs surface was efficiently sterically hindered from biorecognition on the SPR surfaces. when 
the thermosensitive polymer was in the extended conformation, whereas with more Tf and 
fewer pPEGMA chains, there was accessibility to the TfR at the SPR substrate. In addition, the 
data suggested some non-specific binding to the SPR substrates via the pPEGMA chain, while 
the lack of adsorption of the pMPC-AuNP particles to the surfaces indicated that the 
polyzwitterionic layer reduced non-specific adsorption. 
The SPR measurements thus showed that the pPEGMA-Tf-AuNPs and their precursors 
bound to the TfR receptor, i.e. transferrin retained its receptor recognition activity on the 
surface of the particles, as long as it was accessible. The measurements also confirmed that 
there were subtle differences between the interactions of the Tf-AuNPs after the addition of the 
pPEGMA chains and as a function of temperature.  
Internalisation studies of AuNP polymer protein conjugates in HeLa cells 
Selected AuNP conjugates were evaluated for differences in TfR recognition and endocytic 
uptake in cells at different temperatures. These experiments were conducted on HeLa cells, as 
their high expression of transferrin receptors has been well established, and because 
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intracellular trafficking of proteins and nanoparticles in this cell line has been investigated in 
depth.33, 34   
The main hypothesis underlying this study was the possibility for ‘switching’ particle uptake 
into cells by hiding the surface-displayed Tf ligands with the pPEGMA layer at temperatures 
when it was fully hydrated and chain-extended, but revealing the Tf functionality at 
temperatures at which the pPEGMA chains were expected to be collapsed (see Figure 2). This 
temperature, based on the Lower Critical Solution Temperature (LCST) of the polymers in 
solution, is here denoted as aggregation temperature (PAT). Accordingly, live cell imaging 
confocal microscopy was used to evaluate AuNP uptake at two different temperatures, 33 °C 
(i.e. below PAT) and 41 °C (above PAT), for non-thermoresponsive Tf-AuNPs-1-3 and 
thermoresponsive pPEGMA-Tf-AuNP-1-3. HeLa cells were therefore incubated with Tf-
AuNPs and pPEGMA-Tf-AuNPs for 2 hours in serum free medium containing 0.1% BSA, 
washed and imaged immediately (Figure 3). Concentrations were chosen to be low to minimize 
potential self-association of nanoparticles at temperatures above the polymer PAT. In this way, 
we aimed to avoid the introduction of another variable – i.e. particle aggregate size, into the 
analysis of nanoparticle endocytosis, while low concentrations also minimize the possibility of 
saturating transferrin receptors leading to entry of the NPs into cells via a receptor independent 
mechanism. 
The fluorescence microscopy data for AuNP uptake experiments at 33 °C and 41 °C showed 
marked enhancement of endocytosis for the thermoresponsive polymer coated particle 
pPEGMA-Tf-AuNP-3 at temperatures above the expected polymer aggregation temperature 
(41 °C). The fluorescence from 10 individual images totaling >100 cells was quantified from 
three independent experiments revealing a significant (P <0.005) 3.6 fold increase in 
internalization of pPEGMA-Tf-AuNP-3 at 41˚C compared with 33˚C.  This enhancement was 
greater than that observed for AuNPs without the pPEGMA layer (Figure 3).  Analysis of the 
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uptake of Tf alone showed no increase in uptake at 41 °C when compared to 33°C 
(Supplementary Figure S5) indicating that by increasing the temperature there was no increased 
rate of Tf endocytosis. 
 
Figure 3: Effect of temperature-on the endocytosis of AuNPs and conjugates in HeLa cells 
evaluated by confocal microscopy. Images (a-c) and (g-i) show Tf-AuNP-1, -2, -3 at 33 °C and 
41 °C, respectively, while images (d-f) and (j-l) show corresponding polymer-coated particles 
pPEGMA-Tf-AuNP-1, -2, -3 across the same temperature ranges. Scale bars are 20 μm, and 
the micrographs are all contrast enhanced by the same amount to increase clarity in printed 
images. Quantification of particle uptake is given in the lower part of the figure, error bars 
represent standard error from the mean (SEM). Fluorescence intensities from AuNPs were 
normalized for particle number. The p-value for a t-test between 41 ˚C and 33 ˚C of Tf-AuNP-
3 is 0.0036. Fluorescence in images is colored green to represent Alexa488 - original images 
in b/w in Supporting Information. 
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These results suggested a polymer-mediated ‘switch’ of macromolecular receptor-ligand 
interaction, and its subsequent downstream consequences for particle entry into the targeted 
cells. The data also suggest that, under the conditions of these assays, too high a ratio of the 
outer responsive polymer layer to Tf almost completely suppressed particle uptake irrespective 
of whether the responsive polymer was above or below its PAT. Although pPEGMA-Tf-
AuNP-3 nanoparticles were taken up to a four-fold greater extent at a temperature (41 °C) 
above the polymer aggregation temperature compared to below the PAT, the other 
nanoparticles in the series, pPEGMA-Tf-AuNP-1 and 2, with higher pPEGMA chain:Tf ratios 
of ~7 and ~3 (Table 2) were relatively poorly endocytosed even when the polymer chains were 
collapsed.  
In comparison, the uptake of nanoparticles Tf-AuNP-1, Tf-AuNP-2 and Tf-AuNP-3, which 
did not have responsive polymer coatings, was lower than for the responsive polymer-coated 
particles at both 33 °C and 41 °C. Zeta potential measurements of the nanoparticles showed 
that all, irrespective of whether they had a responsive polymer coat, became more negatively 
charged across the 33 °C and 41 °C range. The pPEGMA-Tf-AuNP-3 particles, which were 
endocytosed to the highest extent, were less negatively charged than all the other nanoparticles 
at 41 °C, and aggregated less than the other responsive polymer particles.  However, the higher 
association with cells with these nanoparticles cannot be ascribed to a lower particle repulsion 
with cells at 41 °C alone, since the zeta potentials of these nanoparticles were similar in value 
at 37 and 41 °C 
Intracellular trafficking of AuNP polymer protein conjugates 
The intracellular disposition of the functionalized AuNPs following internalization was then 
investigated, as display of ligands to cognate receptors and their plasma membrane dynamics 
also governs intracellular trafficking.35  We reasoned that Tf would be accessible to the greatest 
extent for the pPEGMA-Tf-AuNP-3 nanoparticles if the experiments were carried out at 41 °C. 
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Fluorescently labelled Dextran was pulse chased into HeLa lysosomes, and the cells were 
subsequently incubated with Tf-AuNPs and pPEGMA-Tf-AuNPs for 2 hours at 41 °C (Figure 
4). 
 
Figure 4: Intracellular localisation of nanoparticles. Lysosomes of HeLa cells were loaded 
with Dextran-A647(red) by incubating the cells with 100 μg/mL Dextran-A647 for 2 h  and 
chasing overnight in serum containing medium.  Cells were incubated with the Tf-AuNPs 
(green) for 2 h in serum free medium containing BSA at 41°C before being washed and imaged.  
Images represent single sections, scale bars = 20 μm, and the ‘zoomed’ micrographs are all 
contrast enhanced by the same amount to increase clarity in printed images.. 
As apparent from Figure 4, at this temperature (41 °C), the highest uptake was exhibited by 
pPEGMA-Tf-AuNP-3, in accord with the prior experiments, but there were no significant 
differences in the intracellular locations of the nanoparticles, with nanoparticles being 
associated with the dextran lysosomal marker after 2 hours.  
 18 
To determine whether pPEGMA-Tf-AuNP-3 was internalized in a Tf receptor-dependent or 
independent manner we incubated cells with both pPEGMA-Tf-AuNP-3 and a 30-fold excess 
of unlabeled Tf for 2 hours at 41°C; a temperature at which the Tf proteins attached to the 
AuNPs were expected to be ‘revealed’ by collapse of the thermoresponsive polymer (Figure 
5). Addition of the free Tf was predicted to out-compete pPEGMA-Tf-AuNP-3 binding to Tf-
receptors, and hence reduce internalization of the nanoparticles through a Tf receptor-mediated 
pathway. Incubation of pPEGMA-Tf-AuNP-3 with excess Tf resulted in a >8 fold decrease in 
the amount of pPEGMA-Tf-AuNP-3 internalized into the cells over 2hrs. The inhibition of 
pPEGMA-Tf-AuNP-3 uptake through Tf competition thus confirmed that the main route of 
internalization of pPEGMA-Tf-AuNP-3 was via the Tf receptor. 
 
Figure 5: Competition of Tf-AuNP-3 and pPEGMA-Tf-AuNP-3 with excess Tf. HeLa cells 
were incubated with either Tf-AuNP-3 or pPEGMA-Tf-AuNP-3 in the presence or absence of 
625 nM Tf for 2 h in serum free medium containing 0.1% BSA at 41°C before washing and 
imaging. Representative images are single section confocal micrographs, error bars = 20 μm. 
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Uptake represents >100 cells from 10 individual images, error bars represent inter-image 
standard deviation. Fluorescence in images is colored green to represent Alexa488 - original 
images in b/w in Supporting Information. 
Tf-TfR is internalized through clathrin dependent endocytosis; upon reaching the early 
endosome iron is released and Tf is recycled back to the plasma membrane. Thus, if pPEGMA-
Tf-AuNP-3 were to follow the complete Tf pathway, the nanoparticles would be expected to 
recycle back out of the cell rather than accumulate within.  However, we have previously shown 
that by linking more than one Tf together at the plasma membrane through the use of biotin-
streptavidin conjugation, Tf is rerouted to the lysosome rather than recycled from the cell.35  
We therefore selected the nanoparticle with the highest uptake at 41 °C, pPEGMA-Tf-AuNP-
3, and carried out consecutive pulse-chase experiments with dextran-A647 labelled dextran, 
and in comparison with a fluorescent Tf analogue, Tf-A488 (Figure 6) to assess whether 
pPEGMA-Tf-AuNP-3 was routed to the lysosome or recycled back out of the cell. 
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Figure 6: Uptake of pPEGMA-Tf-AuNP-3 or equivalent Tf and their lysosomal 
localization over time. Lysosomes were pre-loaded with Dextran-A647 (red) by incubating 
cells with 100 μg/mL Dex647 for 2 h, washed and chased overnight. pPEGAM-Tf-AuNP-3 or 
42 nM Tf-A488 were incubated with the cells for 2 h in serum free medium containing BSA, 
washed with imaging medium containing 10% FBS, imaged immediately and again at 2 h and 
4 h post washing.  Images represent single section confocal images, scale bars = 20 μm, and 
the ‘zoomed’ micrographs are all contrast enhanced by the same amount to increase clarity in 
printed images. 
Uptake of the nanoparticles was again low, but nevertheless, the pPEGMA-Tf-AuNP-3 
signals were apparent in lysosomal compartments at the early time periods. However, the signal 
from Tf was also visible after 6 hours, i.e. considerably in excess of the normal residence time 
of transferrin in normal cell culture. Accordingly, this suggested that at 41 °C and the 
concentrations of Tf used in the assay (42 nM, calculated to be equivalent to those of Tf on the 
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pPEGMA-Tf-AuNP-3 particles), the internalization of Tf occurred via more than one pathway, 
i.e. fluid-phase endocytosis as well as the normal receptor-mediated endocytic pathway. 
However, there was a notable drop in intensity of Tf-A488 following the first 2 h chase 
indicating that some Tf was recycled as expected, but no similar drop in intensity was apparent 
in the fluorescence from pPEGMA-Tf-AuNP-3 suggesting little evidence of recycling.   
 
DISCUSSION 
Functionalisation of nanoparticles with responsive polymer transferrin conjugates 
Transferrin (Tf) has been widely used as a targeting agent for drug delivery and many 
examples exist in the literature reporting the success of Tf-conjugated materials in vitro28, 36-38 
and, to a lesser extent, in vivo.25, 27, 39 In parallel, there has been a number of articles describing 
how responsive polymers have been utilized to control accessibility of small molecule targeting 
ligands through conformational changes.40-42 The combination therefore of responsive 
polymers with Tf functionality seemed an appealing option for controlling cell entry of 
nanoparticles, but at the start of the study there were no reports of macromolecular ligands such 
as Tf being ‘hidden and revealed’ via an external stimulus. In addition, the display of any 
targeting ligand and its presentation to cell-surface receptors is crucial to its activity. The 
Dawson group has pioneered the study of adsorbed protein layers on nanoparticle delivery,43-
45 and showed conclusively that Tf-functionalized nanoparticles can lose targeting specificity 
as a consequence of becoming inaccessible due to protein coating in sera.14 We therefore based 
our design principles around nanoparticles with an inner shell formed of a poly(zwitterion), 
poly(2-methacryloyloxyethyl phosphorylcholine (pMPC), which has been reported to confer 
resistance to protein opsonization,46-48 onto which Tf could be conjugated. As with previous 
studies, we utilized a short oligoethyleneglycol spacer between the Tf and the polymer chain, 
and adopted cyclooctyne click chemistry to connect the protein and spacer to azido-functional 
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side-chains co-polymerized into the pMPC inner shell. We thus expected Tf to retain 
accessibility in the cellular environment in the absence of any further derivatization with an 
outer responsive polymer layer in a hydrophilic ‘stealth’ conformation. In this way, an average 
of 1, 2 and 3 Tf molecules was appended to each of the pMPC-derivatized gold nanoparticles 
(denoted as Tf-AuNP-1, 2 and 3 respectively). The responsive polymer outer layer was also 
attached via click chemistry routes, using a cyclooctyne-terminated pPEGMA with a cloud 
point of 39 °C. The presence of Tf likely provided hindrance to the attachment of the pPEGMA 
chains, as while ~ 7 polymer chains were attached to nanoparticles with one appended Tf, ~ 4 
pPEGMA chains were conjugated to Tf-AuNP-2 and only 2 pPEGMA chains were linked to 
Tf-AuNP-3. This was perhaps not unexpected, as the AuNPs were of 15 nm diameter, the 
pMPC layer was expected to be ~ 5 nm thick based on molar mass and polymer chain length 
calculations, and Tf spans nearly 8 nm in one dimension. The pendant proteins would thus have 
provided a considerable barrier to a ‘brush’ polymer such as the pPEGMA materials 
synthesized for this study, which were themselves likely to have been at least 7 nm in length 
based on calculated end-to-end distances.  
SPR data showed that the pMPC-AuNPs were the least bound of all the NPs at the Tf-receptor 
(TfR) functionalized SPR substrates, confirming the resistance of the primary zwitterionic 
layer to non-specific adsorption at surfaces when in buffered aqueous media.  These 
experiments also demonstrated that the pPEGMA-Tf-AuNPs attached to the greatest extent, 
indicative of a synergistic effect of the thermoresponsive polymer outer layer on surface 
attachment in addition to the expected Tf-TfR bio-recognition interactions. In all cases except 
for the pMPC-AuNPs, attachment to the SPR sensor chip surface increased with temperature, 
again suggestive that the associations with the SPR substrates were not solely a function of Tf-
TfR binding.  
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Nanoparticle internalization in cancer cells 
Investigations of nanoparticle endocytosis were conducted in HeLa cells in accord with 
previous protocols. 41, 42 Conditions of low particle concentration were chosen to minimize self-
association of nanoparticles at temperatures above which the pPEGMA chains were expected 
to undergo coil-to-globule transitions, as this has been a confounding factor in prior responsive 
particle endocytosis experiments,49, 50 but this constraint meant that the assays were close to 
the limits of accurate quantitation of nanoparticle uptake. We also worked in low protein media 
(DMEM + 0.1 % BSA) to reduce the potential for protein corona formation. As apparent from 
Figure 3, the highest internalization was shown by pPEGMA-Tf-AuNP-3 at a temperature (41 
°C) above the PAT of the polymer, with very low uptake of the other NPs at temperatures 
above or below the PAT. While on first inspection this result might be attributed to the intended 
‘switch’ of accessibility of Tf as the polymer chains in pPEGMA-Tf-AuNP-3 collapsed, thus 
revealing the ligand to cell surface receptors, there are other factors which likely affected 
internalization. The pPEGMA-Tf-AuNP-3 particles were the least negatively charged of all the 
NPs in the sample set, and thus were least likely to have invoked charge-charge repulsion at 
HeLa cell surfaces. Similar particle charge effects would not have been as significant in the 
SPR experiments, as the substrates in those assays are dextran-based and thus rather different 
in charge and chemical composition to cell surfaces. Thus it may have been possible that the 
differences in binding behavior of the NPs in the variable-temperature endocytosis study 
compared to those in the SPR assays were a combined function of charge, accessibility of Tf 
and hydrophilicity/hydrophobicity of the pPEGMA outer layer around its aggregation 
temperature. In addition, although there were no proteins in the SPR assay media other than 
Tf, there were proteins (albeit at low concentrations) in the cell culture media used for the 
nanoparticle uptake experiments in HeLa cells. It is therefore possible that adsorption of these 
media proteins to nanoparticles may nevertheless have taken place, and in such a case, the 
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exposed Tf proteins on nanoparticles with no outer pPEGMA layer may have been passivated 
by serum proteins in a manner analogous to that reported by Salvati et al.14 
 
Intracellular trafficking of responsive polymer transferrin conjugate nanoparticles 
The intracellular locations of the internalized nanoparticles were evaluated on the basis that 
a specific transferrin-receptor (TfR) mediated pathway would lead to routing of the 
nanoparticles and entry into a recycling pathway, as has been well characterized for transferrin. 
Again, we kept concentrations low to avoid any self-association of nanoparticles, but the 
experiments showed that while uptake of pPEGMA-Tf-AuNP-3 was highest as expected based 
on the previous data, all the nanoparticles were observed in lysosomal compartments (Figure 
4). This suggested that the Tf-functionalized nanoparticles entered the cells also via some non-
specific uptake routes (i.e, not mediated by Tf), or were re-routed to lysosomes following 
internalization rather than following the conventional Tf recycling pathway, again in accord 
with some of the findings of Salvati et al.14 
Through further investigation we showed a dependence on TfR for the uptake of pPEGMA-
Tf-AuNP-3 particles (Figure 5). This suggested that the majority of these specific particles 
were internalizing through a TfR dependent pathway and being re-routed to the lysosome rather 
than through a non-selective uptake pathway. We have previously shown that binding 
(crosslinking) multiple TfR using biotinylated antibody crosslinked with streptavidin, were re-
routed to the lysosome rather than being recycled. We therefore speculate that the presence of 
more than one Tf protein on each pPEGMA-Tf-AuNP-3 had the ability to cross-link the TfR 
as a result of a multivalent effect and hence drive the particles to the lysosome. However, it has 
been noted before that absolute cell uptake of nanoparticles is not necessarily correlated with 
specific receptor-mediated endocytic processes, as generalized pinocytic routes can lead to 
particle internalization in addition to those via selective ligand-receptor interactions.44  
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An additional complexity in the nanoparticle uptake experiments was the potential for 
changes in both receptor-mediated and generalized pinocytic internalization pathways with 
temperature. We therefore carried out pulse-chase experiments with both Tf-488 and the 
pPEGMA-Tf-AuNP-3 nanoparticles (Figure 6). As apparent from the confocal micrographs in 
Figure 6, there was little change in the fluorescence intensities arising from the pPEGMA-
AuNP-3 in the cells at 2, 4 and 6 hrs and colocalization with the lysosomes was evident from 
the start. This indicated that pPEGMA-Tf-AuNP-3 internalized rapidly and trafficked to the 
lysosome with no recycling. Fluorescence from Tf-488 was apparent after 2hrs with the 
majority not localized to lysosomes, however, after 4 and 6hrs, well-beyond the normal time 
for Tf-recycling, Tf-488 was observed colocalizing with the lysosomal marker although overall 
Tf intensity was lower. These data indicated that a population of Tf was being internalized 
through fluid phase routes and localizing to the lysosome while the remainder was still 
recycling out of the cell.   
The difference in behavior between Tf-488 and pPEGMA-Tf-AuNP-3 suggest there are 
differences in their endocytosis once within the cell. While uptake of pPEGMA-Tf-AuNP-3 
was shown to be through the TfR, these nanoparticles quickly localized to the lysosome and 
showed no evidence of recycling in contrast to Tf-488.  We suspect that in our assays Tf-488 
remained fully bioavailable, thus binding TfR and saturating the receptor (typical KD = 1-
10nM), leading to internalization through alternative, non-specific pathways. However, when 
Tf was attached to pPEGMA-Tf-AuNP-3, its mode of binding to TfR may have prevented 
saturation of the receptor to the same extent as for the rather smaller Tf-488. This in turn may 
have routed pPEGMA-Tf-AuNP-3 to the lysosome, possibly through a receptor crosslinking-
dependent pathway, while the portion of ‘free’ Tf-488 which localized to the lysosome was 
likely to have been Tf-488 which was internalized through non-specific pathways.   
 26 
When considered overall, the results in this study show that while the tailoring of surface 
coating with functional components and targeting agents can be used to control the delivery of 
nanoparticles to cells, there are nevertheless clear confirmations of the inherent complexity of 
cell entry mechanisms for nanoparticles. Our data for lysosomal accumulation of Tf-bearing 
nanoparticles were as noted above in accord with those of Salvati et al who observed similar 
trafficking for Tf-PEG-silica nanoparticles,14 but different to those of Choe et al who reported 
recycling of Tf-tagged polypeptide vesicles.38 Our results showed that the pPEGMA-Tf-AuNP-
3 particles were the most internalized of all those tested at 41 °C, i.e. when the outermost 
polymer chains on their surface were expected to be collapsed and Tf exposed to interact with 
cell surface receptors. However, our data also indicated that particles may internalize by non-
Tf pathways too, and thus it is likely that a combination of ligand accessibility, surface 
hydrophobicity and surface charge were all contributors to the endocytic mechanisms and the 
enhanced accumulation of pPEGMA-Tf-AuNP-3 compared to the other nanoparticles. 
It should also be noted that extension of these studies to an in vivo setting would require 
verification first that the nanoparticles retain accessibility of the Tf ligand in the circulatory 
system or in any extracellular matrix in which these materials might be injected.14 There is also 
the caveat that the outer responsive layer becomes more protein adsorbent when it is chain-
collapsed. Thus, under conditions of local hyperthermia in vivo, which can occur via external 
stimulus or local disease in tissues such as solid tumors, the exposure time for the nanoparticles 
prior to encounter with cell surface transferrin receptors might be critical for in determining 
whether the outer layer adsorbs a ‘blocking’ corona of extracellular matrix biopolymers.13, 51 
Nevertheless, the initial indication that nanoparticle endocytosis can be switched by 
hiding/revealing a protein ligand in cell culture conditions is promising, and suggests that if a 
polymer conformational and steric barrier change could be triggered without invoking a 
 27 
concomitant alteration in nanoparticle surface hydrophobicity, a powerful means to target 
specific cells or tissues via external stimulus could result. 
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Experimental Section 
 
Materials 
Thio-transferrin52 was kindly donated by Albumedix Ltd, Nottingham, UK and used as 
received. PD SpinTrap G-25 columns, Disposable PD-10 Desalting Columns, Vivaspin 6 
(MWCO 100K), Hiprep 26/60 columns, Biacore NTA sensor chip, NTA reagent kit and HBS-
P buffer were purchased from GE Healthcare Life Sciences. Alexa Fluor 488-SDP and 
Dulbecco's Modified Eagle Medium (DMEM) without phenol red was purchased from Thermo 
Fisher Scientific. Hydrogen tetrachloroaurate hydrate (99.999% trace metal basis) was 
purchased from Acros Organics. All solvents and reagents were of analytical or HPLC grade 
and purchased from Sigma Aldrich unless otherwise specified. Tri(ethylene glycol)ethyl ether 
methacrylate (TriEGMA, Mn 246 g mol
-1) and polyethylene methyl ether methacrylate 
(pPEGMA, Mn 475 g mol
-1) were purchased from Sigma-Aldrich and purified by passing 
through a column filled with basic alumina before use. Holo-Transferrin Human (≥ 98%), 2-
Methacryloyloxyethyl phosphorylcholine (MPC, 97%), 2-[2-(2-Chloroethoxy)ethoxy]ethanol 
(96%), Sodium azide (≥ 99.5%), Potassium iodide (≥ 99%),  Triethylamine (Et3N (≥99%)), 
Methacryloyl chloride (97%), (±)-α-Lipoic acid (98%), 2-Hydroxyethyl disulfide (90%), N,N′-
Diisopropylcarbodiimide (DIC, ≥98%), 4-(Dimethylamino)pyridine (DMAP, ≥98%), α-
Bromoisobutyryl bromide (98%), 2,2’-bipyridyl (≥98%), Dibenzocyclooctyne-PEG4-
maleimide, 5,5′-Dithiobis(2-nitrobenzoic acid) (≥98%), Copper (II) Bromide (Cu(II)Br2, 99%), 
Copper (I) Bromide (Cu(I)Br, >98%), Ethylenediaminetetraacetic acid disodium salt (EDTA, 
>99%), Fetal Calf Serum (FCS) and PBS Dulbecco (Modified, without calcium chloride and 
magnesium chloride) were purchased from Sigma Aldrich. 
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NMR analysis 
1H NMR spectra were recorded on a Bruker 400 spectrometer at 399.8 MHz (1H) and 100.5 
MHz (13C) with samples prepared in in CDCl3 or D2O. All chemical shifts are reported in ppm 
relative to TMS. 
 
Gel Permeation Chromatography (GPC) analysis 
Organic solvent conditions: 
Gel Permeation Chromatography (GPC) was performed on a Polymer Labs GPC 50 Plus 
system fitted with a differential refractive index detector. Separations were performed on a pair 
of PLgel Mixed-D columns (300 7.8 mm, 5 mm bead size, Polymer Labs UK) fitted with a 
matching guard column (50 7.8 mm). Chromatograms were run at 40 °C using chloroform 
(CHCl3) as eluent with a flow rate of 1 ml/min. Column calibration was achieved using narrow 
polystyrene standards (160 Da–240 kDa, Agilent, UK).  
Aqueous solvent conditions: 
Aqueous GPC was performed on a Shimadzu Prominence UPLC system fitted with a DGU-
20A5 degasser, LC-20AD, CBM-20A LITE system controller, SIL-20A autosampler, CTO-
20A oven and RID-10A refractive index detector. Separations were performed on a series of 
Aquagel 30-40-50 (300 x 7.8 mm, 5 mm bead size, Agilent UK) columns fitted with a matching 
guard column (50 x 7.8 mm). Analysis was carried out at 35°C. The mobile phase was 
Dulbecco PBS buffer pH 7.4 at a flow rate of 1 mL/min. Column calibration was achieved 
using Polyethylene oxide/glycol EasiVials (2 mL) standards (196 Da–498 kDa, Agilent UK). 
 
 
 
Protein and polymer bioconjugate analysis 
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Aqueous GPC for bioconjugates was performed on a Shimadzu Prominence UPLC system 
as above. Protein conjugate: GPC analysis was performed in isotonic PBS pH 7.4 (Dulbecco) 
using a TSKgel G3000SWXL, TOSOH column, UV absorbance was recorded at 220/280 nm. 
Thermoresponsive polymers: GPC analysis for responsive polymer-protein conjugates was 
performed in isotonic PBS pH 7.4 (Dulbecco, DPBS) with 10% methanol using a Aquagel 30 
column (Polymer Labs), UV absorbance was recorded at 220 nm. 
 
UV-Vis analysis 
UV-Vis spectra for AuNPs solutions were recorded on a Cary UV/Vis spectrometer over the 
range 200-800 nm.  
Cloud point analysis of polymers/AuNP protein polymer conjugates and colloidal stability 
analysis of AuNP in media were carried out using a Beckman DU 800 UV/Vis 
Spectrophotometer with a Peltier Temperature Controller. 
 
Cloud point measurements 
UV absorbance was recorded at 550 nm (or 534 nm). The samples solutions were heated 
from 20C to 65C using a temperature gradient of 0.5C/min and UV readings were recorded 
every 0.5C.  
 
Centrifugal purification 
High speed centrifuge - Particles were separated by centrifugation using a Beckman J2 
centrifuge with JA-17 fixed angle rotor. Particles were centrifuged at 4C and 21 kG for 45 
minutes. The supernatant was recovered, the particle resuspended in isotonic PBS and the 
process repeated as required. 
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Low speed centrifuge (bench centrifuge) – Particles were concentrated at room temperature 
using a Technico Maxi bench centrifuge. The solutions were transferred to 1.5 mL Eppendorfs 
and centrifuged at 16kG for 45 minutes. The particles were resuspended in a small amount of 
isotonic PBS, sterile filtered (0.22 µm PES) and kept in fridge until further analysis. 
 
Zeta potential measurements  
Zeta potential measurements and hydrodynamic radii of the AuNP-protein polymer 
conjugates were measured using a Malvern Zetasizer Nano ZS. Dynamic light scattering (DLS) 
at 173 angle and z-potential measurements were performed at 33C, 37C and 41C. Samples 
were allowed to equilibrate for 8 minutes at each new temperature before acquisition. All 
samples were prepared in 1/100 DPBS buffer. Data analysis was carried out using Zetasizer 
Software (version 7.11).  
 
Dynamic light scattering (DLS) 
Dynamic light-scattering was performed using a Viscotek 802 DLS instrument fitted with an 
internal laser (λ 830nm ± 5 nm, Pmax 60 mW). Laser power was adjusted until a detection rate 
of at least 300 kcps was achieved. The samples were measured across a temperature range of 
25-41C. Experimental scattering data were recorded for three seconds for each sample and 
repeated ten times for each temperature point. Hydrodynamic radii distributions were 
calculated with Viscotek/Malvern OmniSize3 software. 
 
 
 
 
Size exclusion purification 
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Protein and gold colloid purifications were carried out using a Hi-Prep 26/60 (Sephacryl S-
200) column. Separations were carried out in isotonic PBS on Agilent 971-FP system using 
UV detection at 220/280 nm and a flowrate of 2.0 mL/min. 
 
SPR analysis 
Surface plasma resonance (SPR) analysis was carried out on a Biacore 3000 instrument using 
a NTA chip. The NTA chip was activated according to manufacturer’s specification. TfR-His 
tag was used to conjugate to the Ni decorated surface, RU= 800 (reference channel was left 
unmodified). HBS-P buffer supplemented with 200 mM NaCl was used as the running buffer 
at a flowrate of 50 µL/min. A 120 second injection time was used for each injection, followed 
by 6 minutes dissociation. The surfaces were regenerated by washing with 3M NaCl for 4 
minutes and then allowing to equilibrate for 15 minutes before subsequent injections. AuNP 
stocks were diluted by a factor of 16 to 50 depending on AuNP initial concentration in order to 
normalize concentrations. Binding experiments were carried out at 25C and 37C 
respectively. 
 
TEM analysis 
Transmission Electron Microscopy (TEM) analysis was performed on a FEI Tecnai 12 
Biotwin transmission electron microscope. Solutions of AuNP aqueous samples (10 µL) were 
placed on a TEM copper grid coated with formvar carbon film for a few minutes. The excess 
solution was subsequently removed with filter paper and the grid dried over 2-3 hours before 
TEM imaging. 
 
 
Colloidal stability 
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The AuNP solutions were diluted with DMEM by a factor of 15.5 to 31 depending on AuNP 
initial concentration in order to normalize concentrations. The solutions were placed in a 
spectrophotometer at 37 C and the absorbance monitored at λ = 534 nm (AuNP maximum) 
over a period of 240 minutes. A reading for each sample was taken every 20 seconds. 
Absorbance readings were normalized for each AuNP batch to 100% at t= 0 minutes. 
 
Synthesis of 14-bromo-14-methyl-13-oxo-3,6,9,12-tetraoxapentadecyl 5-(1,2-dithiolan-3-
yl)pentanoate (Lipoic acid–TEG-ATRP initiator) (Compound 1, Figure 1) 
Precursor compound 2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl 2-bromo-2-
methylpropanoate (HO-TEG-Br) was synthesized and analyzed as reported previously.53  
(±)-α-Lipoic acid (0.75 g, 3.6 mmol) and HO-TEG-Br (1.2 g, 3.5 mmol) were weighed out 
and placed in a round bottom flask. The compounds were dissolved in anhydrous 
dichloromethane (50 mL) and the solution cooled down to 0 C in an ice bath. 
Diisopropylcarbodiimide (DIC, 0.92 g, 7.3 mmol) and DMAP (catalytic amount) were added 
to the solution. The solution was allowed to heat up to room temperature and then left to react 
overnight. The following day the solution was filtered and the precipitate discarded. The 
solvent was removed under reduced pressure and the product purified by silica column 
chromatography using a 20% n-hexane/80% Et2O  100% Et2O solvent mixture. The Lipoic 
–TEG-ATRP initiator was collected as yellowish oil (1.3g, 70% yield). 1H NMR (CDCl3, 400 
MHz): δ 4.34-4.32 (t, 2H), 4.24-4.2 (t, 2H), 3.76-3.73 (t, 2H), 3.72-3.62 (m, 10H), 3.60-3.53 
(m, 1H), 3.22-3.08 (m, 2H), 2.50-2.42 (m, 1H), 2.38-2.33 (m, 2H), 1.94 (s, 6H), 1.94-1.87 
(m,1H), 1.74-1.64 (m,4H), 1.55-1.38 (m,2H). 13C NMR (CDCl3, 100 MHz): δ 173.44, 171.62, 
70.75, 70.67, 70.65, 70.59, 69.19, 68.77, 65.13, 63.46, 56.34, 55.72, 40.22, 38.49, 34.60, 33.95, 
30.77, 28.74, 24.62.  
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Synthesis of 2-(2-(2-azidoethoxy)ethoxy)ethyl methacrylate (Azido-TriEG-Methacrylate) 
(Compound 2 Figure 1). 
2-(2-(2-Chloroethoxy)ethoxy)ethanol (20 g, 0.12 mol), sodium azide (15.4 g, 0.227 mol) and 
potassium iodide ( ~ 0.5 mol % added as catalyst) were placed in a round bottom flask and 
dissolved in 100 mL of water. The mixture was heated under reflux at 100 C for 3 days. The 
solution was then cooled down and the product extracted with ethyl acetate (3 x 100 mL). The 
organic layer was dried with sodium sulfate and then removed under reduced pressure. Azido-
TriEG was recovered as yellowish oil (18g, 86% yield). 1H NMR (Acetone-d6, 400 MHz): δ 
3.71-3.69 (t, 2H), 3.68-3.60 (m, 6H), 3.56-3.53 (t, 2H), 3.42-3.39 (t, 2H).13C NMR (Acetone-
d6, 100 MHz): δ 72.67, 70.3 (multiple signals), 69.8, 61.1, 50.50.  
Azido-TriEG (3.0 g, 0.017 mol) was placed in a sealed round bottom flask and dissolved in 
anhydrous DCM (50 mL). The solution was cooled down to 0C in an ice bath and 
triethylamine (2.6 g, 0.025 mol) was added. Methacryloyl chloride (1.8 g, 0.017 mol) was 
subsequently added dropwise to the reaction, and allowed to react overnight. The solution was 
then filtered, and the precipitate discarded. The solvent was removed under reduced pressure 
and the product purified by silica chromatography (mobile phase: 66 % n-hexane/33% ethyl 
acetate vol:vol). Azido-TriEG-Methacrylate was recovered as yellowish oil (3.5 g, 85% yield). 
1H NMR (CDCl3, 400 MHz): δ 6.14-6.13 (m, 1H), 5.58 (m, 1H), 4.32-4.30 (t, 2H), 3.77-3.75 
(t, 2H), 3.70-3.66 (m, 6H), 3.40-3.38(m, 2H), 1.96-1.95(s, 3H). 13C NMR (CDCl3, 100 MHz): 
δ 167.35, 136.17, 125.71, 70.72-69.25 (multiple signals), 63.85, 50.70, 18.31.  
 
Synthesis of disulfanediylbis(ethane-2,1-diyl) bis(2-bromo-2-methylpropanoate) 
(Disulfide ATRP initiator) (Compound 3 in Figure 1). 
2-Hydroxyethyl disulfide (11 g, 0.071 mol) was placed in a round bottom flask and dissolved 
in anhydrous DCM (100 mL). The solution was cooled down to 0C in an ice bath and 
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triethylamine (14.9 g, 0.146 mol) was added. Bromoisobutyryl bromide (32 g, 0.14 mol) was 
added dropwise to the reaction and allowed to react overnight. The solution was then filtered 
and the precipitate discarded. The solvent was removed under reduced pressure and the product 
purified with silica chromatography (mobile phase: 50 % n-hexane/50% Et2O). The product 
was recovered as a yellow oil (25 g, 77% yield).  
1H NMR (CDCl3, 400 MHz): δ 4.46-4.43 (t, 4H), 3.00-2.97 (t, 4H), 1.95-1.94 (s, 12H) 13C 
NMR (CDCl3, 100 MHz): δ 171.43, 63.52, 55.51, 36.78, 30.73. 
 
Preparation of end- and side-chain reactive poly(2-methacryloyloxyethyl 
phosphorylcholine)s (Corona polymer CP-1)  
Lipoic–TEG-ATRP initiator (1, Figure 1; 30 mg, 0.05 mmol) was dissolved in 4.3 mL of 
deoxygenated methanol and transferred into a sealed round bottom flask. Cu(I)Br (8 mg, 0.05 
mmol) and 2,2’ bipyridyl (18 mg, 11 mmol) were added to the flask and allowed to dissolve 
completely. The polymerization was initiated by the addition of the MPC monomer (1.67 g, 
5.64 mmol). Conversion of the polymerization was monitored using 1H-NMR. When the 
conversion of monomer had reached 82% (150 minutes), a deoxygenated solution of MPC 
monomer (167 mg, 0.56 mmol) and Azido-TriEG-Methacrylate (compound 2, Figure 1, 35 mg, 
0.28 mmol) was added using a cannula. The polymerization was stopped after 210 minutes by 
exposing the solution to air. Total conversion after 210 minutes was 85% by 1H-NMR.  Copper, 
bipyridyl and monomer were removed by dialysis (MWCO 6-8000) in water in the presence of 
EDTA. The dialysis bag was placed into pure water before lyophilisation and collection of the 
polymer. A white crystalline powder (1.0 g) was collected after lyophilisation (lipoate-
terminated and azide-functional polyMPC, corona polymer CP-1). Monomer conversion was 
calculated from 1H-NMR spectra by comparing the vinyl proton signals from the monomers 
(5.6 and 6.1 ppm) to the integration of 6 MPC protons from 4.3 to 3.9 ppm. 
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The monomer composition of CP-1 was calculated by comparing the ratio of the methyl (-
CH3, 9H) signals for MPC at 3.18 ppm to the CH2 signals from MPC (2H) and Azido-TriEG 
(8H) at 3.6 ppm. For every unit of MPC in the final polymer there were 0.028 units of Azido-
TriEG present. The degree of polymerization was ~110, indicating ~ 3 units of Azido-TriEG 
were present in the final polymer. 
Molar masses and mass distributions of polymers were determined using aqueous gel 
permeation chromatography (DPBS, Aquagels 30-40-50).  
 
pPEGMA polymerization  
Disulfide ATRP initiator (compound 3, Figure 1, 50 mg, 0.11 mmol), DiEGMA (3.6 g, 19 
mmol), PEGMA475 (1.5g, 3.1 mmol) and 2,2’-bipyridyl (69 mg, 0.44 mmol) were placed in a 
round bottom flask, dissolved in 15 mL of toluene and the flask sealed. The solution was 
deoxygenated by bubbling argon through it for 30 minutes. The reaction heated to 70C and 
Cu(I)Cl (22 mg, 0.22 mmol) was added to the flask to start the polymerization. The 
polymerization was allowed to progress overnight. The following morning the polymerization 
was stopped by exposing the reaction to oxygen and cooling it down. Monomer conversion 
was calculated from 1H-NMR spectra by comparing two the vinyl proton signals from the 
DiEGMA and PEGMA475 monomers (5.6 and 6.2 ppm) to the integration of protons from 4.4 
to 4.0 ppm. In the region of 4.0-4.4 ppm two protons from the polymer resonate plus two 
protons from the monomers. Conversion was calculated by subtracting the monomer signal in 
the region 4.0-4.4 ppm from the total integration and dividing it with the total integration signal. 
The conversion of the polymerization was 95% by 1H-NMR. Degree of polymerization was 
therefore 95 units per polymer chain according to 1H-NMR analysis. The polymer was purified 
by passing the polymer solution through a short column of alumina and precipitation into a 
mixture of hexane/ether (75/25). The precipitate was dissolved in DCM and the polymer 
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precipitated again in a hexane/ether mixture, this process was repeated twice. The pPEGMA 
disulfide polymer (1.7 g) was recovered as a yellowish sticky oil.  
The composition of PEGMA475 and DiEGMA in the polymer was calculated from the NMR 
spectra of the purified polymer in CDCl3. The ratio of PEGMA 475 to DiEGMA in the polymer 
was determined by comparing the integral of the methoxy (-OMe) protons (3.45-3.35 ppm) to 
the ethylene glycol polymer backbone (3.85- 3.55 ppm). In the ethylene glycol polymer region 
the PEGMA475 has 34 protons while DiEGMA has 6 protons relative to the methoxy protons 
(-OMe). The purified polymer had 9.54 protons in the ethylene glycol region. The molecular 
composition of the purified polymer was thus 12.6% PEGMA475 and 87.4% DiEGMA, i.e. 
34xPEGMA475 + 6xDiEGMA = 9.54 (DiEGMA+PEGMA475= 1). 
Molar masses and mass distributions of polymers were determined using organic gel 
permeation chromatography (Chloroform, PLgel Mixed-D Columns).  
 
Synthesis of thermoresponsive polymer TRP-1 by pPEGMA-disulfide polymer reduction 
and DBCO functionalisation 
Reduction of pPEGMA-disulfide: A sample of pPEGMA-disulfide (264 mg, 6.3 µmol) was 
dissolved in 1 mL isotonic PBS (pH 7.4). To this, an aliquot (0.4 mL) of 0.5 M EDTA solution 
(pH 8.0) was added, to give a 50 mM final EDTA concentration. Then, a sample (0.32 mL) of 
a 25 mg/mL TCEP solution (18 mg, 63 µmol) was added to the polymer solution and the 
reaction was continued overnight at 4 °C. The following morning the solution was passed 
through a PD10 desalting column (eluent PBS and 5 mM EDTA) to remove the free TCEP 
from the solution. The cleaved polymer was characterized in terms of molar mass by GPC 
(CHCl3) and for thiol content by Ellman assays. The polymer solution, denoted as pPEGMA-
SH was kept at 4 °C prior to maleimide conjugation. 
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DBCO functionalization: pPEGMA-SH (82 mg, 3.3 µmol) in 2.25 mL of isotonic PBS pH 
7.4 containing 5 mM EDTA was mixed with dibenzocyclooctyne-PEG4-maleimide linker 
(16.2 mg, 24 µmol (DMSO stock 50 mg/mL)) and allowed to react overnight at 4 °C. The 
solution was then passed through a PD10 desalting column using a DPBS eluent to remove the 
free DBCO linker from the reaction. The extent of modification was verified via Ellman assays 
and the resultant conjugate polymer checked by GPC to ensure no oxidation had occurred 
during the conjugation. Polymer solutions were stored at 4 °C. 
 
Gold nanoparticle (AuNP) synthesis 
A solution of HAuClO4 (393 mL, 1.0 mM) was placed in a 500 mL round bottom flask and 
heated up to 100 C.   A solution of aqueous sodium citrate tribasic (137.5 mL, 38.8 mM) at ~ 
100 C was added to the gold solution, gently agitated and allowed to react for 10 minutes. 
After 10 minutes the solution was cooled down to room temperature and then stored at 4 C 
until required. 
Particles were analyzed by UV-Vis, and disc centrifuge (CPS). Calculations of nanoparticle 
numbers used in experimental assays were based on measurements of particle size (CPS), the 
density of gold and dilutions of stock solutions of known concentration. 
 
AuNP functionalization with polymer CP-1 
A solution of AuNPs (400 mL, 1.71 x 1015 particles total, 2.84 nmol) was measured into 
polypropylene (PP) containers. Corona polymer CP-1 (355 mg, 14,200 nmol, 5000 eq,) was 
dissolved in 4 mL of water and distributed equally among the AuNP-containing containers. 
The containers were placed on rollers at room temperature and allowed to react overnight. The 
AuNP solutions were transferred into 50 mL PP centrifugal tubes and centrifuged (21kG at 
4C) for 45 minutes, the supernatant was removed and kept for analysis. The polymer 
 39 
concentration in the initial supernatant was estimated using Aqueous GPC (TSKgel) and 
compared to that of the initial polymer stock in order to estimate polymer grafting onto the 
AuNPs. The pellets were then resuspended in isotonic PBS, centrifuged again at 21kG for 
further 45 minutes and the supernatant discarded. This process was repeated once. The pellets 
were subsequently dissolved in a minimal amount of PBS and transferred into Eppendorf tubes. 
The solutions were centrifuged at 16kG for 45 minutes and the supernatant discarded. The 
pellets were redissolved in PBS and the process repeated once. Finally all the pellets were 
redissolved in PBS and all the aliquots pooled together (12.8 mL total volume). The polymer-
AuNP (AuNP-CP-1) solutions were filtered through 0.22 µm PES membrane. Small portions 
of the purified AuNP-CP-1 solutions were centrifuged and analyzed for free polymer by GPC 
in order to ensure the purification was complete. The particle concentration was measured by 
spectroscopy and compared to particle concentration of the stock AuNP solution to determine 
the recovery yield.  Particle recovery was almost quantitative and aqueous GPC of the 
supernatant revealed that 10% of the polymer had conjugated to the AuNP, i.e. ~ 500 polymer 
chains were grafted onto each AuNP. The concentration of the purified AuNP-CP-1 solution 
was 1.34 x1014 NP/mL. 
 
Thio-transferrin- Dibenzocyclooctyne/Alexa Fluor 488 functionalisation  
An aliquot (7 mL) of a 5 mg/mL thiotransferrin solution (Tf content, 35 mg, 0.4 µmoles) in 
10 mM HEPES pH 7.4 was taken from -80C freezer, gently thawed and allowed to reach room 
temperature. Dibenzocyclooctyne-PEG4-maleimide (DBCO) linker was dissolved in DMSO 
in order to make a 50 mg/mL stock solution. A sample from this stock solution (8 µL= 0.41 
mg, 0.6 µmol DBCO) was added to protein solution and allowed to react for 3 hours at room 
temperature. The mixture was subsequently purified using a HiPREP 26/60 column to remove 
any thio-Tf protein dimers and unreacted DBCO linker. Purity was determined by GPC 
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(TSKgel, DPBS) analysis and compared to the starting thioTf. The concentration of the purified 
TF-DBCO and subsequent yield of recovery was determined by UV spectroscopy at λ = 280 
nm. Recovery of thioTf after HiPrep purification was 17 mg (49% protein recovery). GPC 
analysis of the purified conjugate revealed that the Tf-DBCO was 70% pure, with approx. 30% 
unconjugated Tf species. The Tf-DBCO conjugate was stored at 4 °C. 
 
Tf-DBCO Alexa Fluor 488 SDP conjugation:  
The reactive dye Alexa Fluor 488 SDP (AF488 SDP) (1 mg) was dissolved in 0.1 mL of 
anhydrous DMSO to form a 10 mg/mL stock. An aliquot of1.0 mL of Tf-DBCO (14.3 mg, 
0.178 µmol) in isotonic PBS pH 7.4 was mixed with 0.2 mL of 1 M Sodium bicarbonate buffer 
pH 8.3. An aliquot (73 µL) of AF488 SDP stock solution (AF488SDP content = 0.737 mg, 
0.893 µmol, 5 molar eq. to Tf) was added to the protein solution while the solution was gently 
stirred. The solution was reacted overnight at 4 °C. The unreacted dye was removed using a 
PD10 column (gravity protocol) and isotonic PBS as eluent. The Tf-DBCO-AF488 conjugate 
was recovered after PD10 purification. The protein concentration/dye ratio was determined by 
UV-vis absorbance at λ = 280/494 nm and calculated according to the manufacturer’s 
(Invitrogen) specifications.33 A total of 13.6 mg of Tf-DBCO-AF488 (30% TF-AF488) was 
recovered after gel permeation  chromatography purification, and the level of Alexa Fluor 488 
labelling was 2.7 dye molecules per protein. The Tf-DBCO-AF488 was aliquoted into 
Eppendorf tubes, frozen with liquid nitrogen and stored at -80C. 
  
Tf-DBCO - Particle conjugation 
AuNP-CP-1 stock solution was transferred into 15 mL falcon tubes and diluted by a factor 
of two using isotonic PBS. Tf-DBCO-AF488 (3.9 mg/mL stock ~ 70% pure) was added to the 
falcon tubes in appropriate amount to give a particle ratio of two, four and eight Tf per AuNP. 
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The AuNP-Tf solutions were allowed to react at 4C for 3 days at low speed on an orbital 
shaker. After 3 days the solutions were diluted down to a total volume of 15 mL using isotonic 
PBS. The particles were transferred to 50 mL centrifuge tubes and centrifuged at 21kG for 45 
minutes at 4C.  The supernatant was collected and AF488 fluorescence quantified by 
spectrofluorometry. Protein grafting density was determined by comparing the AF488 
fluorescence in the supernatant to that of the protein AF488 stock. The pellets were then 
resuspended in PBS (50 mL each), the solutions centrifuged again at 21kG for 45 minutes and 
the supernatant discarded. This process was repeated once. The pellets were subsequently 
dissolved in a minimal amount of PBS and each batch transferred to Eppendorf tubes. The 
solutions were then centrifuged at 16kG for 45 minutes and the supernatant discarded. The 
pellets were redissolved in PBS and the process repeated once. Finally all the pellets were 
redissolved in PBS and the aliquots pooled together. The AuNP-CP-1-Tf solutions were filtered 
through a 0.22 µm PES membrane. The particle concentrations were estimated by UV and 
particle recovery determined by comparison to the initial stock AuNP Lipoic-MPC-N3 solution. 
 
Tf – AuNP pPEGMA polymer particle coating 
The solutions of AuNP-CP-1 conjugated with Tf (Tf-AuNP-1, Tf-AuNP-2, Tf-AuNP-3) 
were transferred with a pipette into 1.5 mL Eppendorf tubes. pPEGMA-DBCO was dissolved 
in isotonic PBS pH 7.4 (33.9 mg/mL). Twenty-six µL of the pPEGMA-DBCO stock solution 
(882 µg, 41 nmoles, 100 eq. per AuNP) was added to each batch of AuNP and allowed to react 
for 3 days at 4C at low speed on an orbital shaker. After 3 days the particles were centrifuged 
at 21kG for 45 minutes and the supernatant collected. The particles were transferred to 50 mL 
centrifuged tubes, diluted with isotonic PBS and centrifuged at 21kG for 45 minutes at 4C.  
This process was repeated twice. The pellets were afterwards dissolved in minimal amount of 
PBS and each batch transferred to Eppendorf tubes. The solutions were then centrifuged at 
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16kG for 45 minutes and the supernatant discarded. The pellets were redissolved in PBS and 
the process repeated once. Finally all the pellets were redissolved in PBS, the aliquots pooled 
together and the resultant pPEGMA-conjugated Tf-AuNP solutions were filtered through 0.22 
µm PES membrane. 
Polymer grafting density to the AuNP was determined by measuring the concentration of 
polymer in the supernatant by aqueous GPC with 10% methanol and comparing to the polymer 
stock concentration. The particle concentration was estimated by UV and particle recovery 
determined by comparison to the initial stock AuNP-Tf solution. 
 
Cloud point analysis of pPEGMA-Tf-AuNP conjugates in DMEM 
The stock solutions of pPEGMA-Tf-AuNPs in PBS were diluted 15.5 times with DMEM 
and their turbidity monitored as a function of temperature. The samples solutions were heated 
from 20C to 65C using a temperature gradient of 1C/min and UV readings were recorded 
every 0.3C at 534 nm.  
 
Cell culture 
HeLa cells were cultured in DMEM (Fisher Scientific, Loughborough, UK) supplemented 
with 10% FBS (Gibco, Fisher Scientific, formally Invitrogen, Paisley, UK) under standard 
tissue culture conditions (at 37°C, 5% CO2 in a humidified incubator) and passaged (no greater 
than 20 times) before reaching 80% confluency.  HeLa cells were obtained from ATCC, 
routinely tested for the absence of mycoplasma and were not cultured in the presence of 
antibiotics. 
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Uptake analysis of AuNPs and Transferrin competition 
The day before experimentation 275,000 cells were seeded into a glass bottomed imaging 
dish (MatTek, Ashland, MA, USA) in DMEM containing 10 % FBS and allowed to adhere 
overnight under standard tissue culture conditions.  On the day of experiment, cells were 
washed three times in imaging medium (phenol red free DMEM containing 20 mM HEPES, 
[Fisher Scientific, Loughborough, UK] supplemented with 0.1% BSA [Fisher Scientific]) and 
incubated with 0.85x1012 AuNPs at a concentration of 4.25x1012 AuNPs/mL for 2 h in imaging 
medium at either 33°C or 41°C in a humidified 5% CO2 incubator. Cells were subsequently 
washed three times in imaging medium and immediately imaged on a Leica SP5 confocal 
microscope (488 nm laser, with x63 objective, rastor size of 1024 square giving a pixel size of 
151 nm square, images were obtained at 200 Hz, with a line average of three). 
For transferrin competition assays, samples were setup as above with the addition (or 
absence) of 50 µg/mL (625 nM) holo-Tf-Biotin (Sigma Aldrich, Gillingham, UK), in addition 
to the AuNPs.  For the control Tf uptake assay, Tf-Alexa488 (Fisher Scientific) was added at 
25 nM in place of AuNPs and treated as above. 
Quantification was performed using the method developed by Moody et al.35 In brief, ten 
individual images were analyzed per sample with the mean of these ten giving a value for an 
independent experiment.  The mean was taken for three individual experiments with the 
standard error of the mean calculated and plotted. An unpaired two-tailed t-test was used for 
the comparison of pPEGMA-Tf-AuNP-3 at 41°C and 33°C only. In all other cases, an ANOVA 
with post-hoc Tukey’s test was performed at a significance level of P<0.05 was calculated for 
a comparison of all samples (where pPEGMA-Tf-AuNP-3 at 41°C and 33°C proved 
significant). 
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Labelling lysosomes 
Cells seeded at 225,000 cells per imaging dish were allowed to adhere for 24 hours before 
incubation with 100 μg/mL Dextran-Alexa647 for two hours in DMEM containing 10% FBS. 
Cells were washed three times and incubated overnight in fresh DMEM containing 10% FBS 
to label lysosomes as described previously.35 
 
Uptake time course and colocalization with lysosome 
Cell lysosomes were labelled as above.  On the day of the experiment, cells were incubated 
with either pPEGMA-Tf-AuNP-3 at 1.7x1012 AuNPs per imaging dish (a concentration of 
8.5x1012 AuNPs per mL, thus giving an effective Tf concentration of 42 nM per dish) or with 
42 nM Tf-Alexa488 for 2hrs in serum free DMEM containing 0.1% BSA for 2 hrs at 41 °C 5% 
CO2 before washing and imaging. This higher concentration facilitated microscopy 
determination of pPEGMA-Tf-AuNP-3 within the cells, so that a stronger signal could be 
obtained above background fluorescence. Cells were subsequently reimaged 4 hours and 6 
hours post initial incubation via confocal microscopy (488nm and 633nm lasers, with x63 
objective, a zoom of 1.73, rastor size of 1024 square giving a pixel size of 139 nm square, 
equivalent to the resolution limit for this system). Images were obtained at 200Hz, with a line 
average of three). 
 
Supporting Information. Cloud point analysis, transmission electron microscopy, surface 
plasmon resonance data, dynamic light scattering and zeta potential measurements. This 
material is available free of charge via the Internet at http://pubs.acs.org.  
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Graphical abstract. Thermoresponsive polymers are used to coat gold nanoparticles with 
surface-displayed transferrin functionality. Control of transferrin-receptor binding and 
subsequent internalization into HeLa cells of the gold nanoparticles is modulated by reversible 
conformational changes of the thermoresponsive polymers.  
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Figure S1 –TEM analysis of functionalized gold nanoparticles; a) Tf-AuNP-1, b) Tf-AuNP-2, 
c) pPEGMA-AuNP-1, d) pPEGMA-AuNP-3. Scale bar = 100 nm  
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Figure S2 – Cloud point analysis of thermoresponsive polymers before reduction and after 
derivatization with DBCO. Transition onset: pPEGMA disulfide – 38.2 C, pPEGMA-SH – 
38.5 C, pPEGMA – DBCO (5 mg/mL) = 35.8 C, pPEGMA – DBCO (2.5 mg/mL) = 37.2 C, 
pPEGMA – DBCO (1.25 mg/mL) = 38.9 C. 
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Figure S3 – Colloidal stability of nanoparticles in DMEM media. 
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Figure S4: SPR affinity of nanoparticles batches towards transferrin receptor at 25 °C and 37 
°C. In a) pMPC-AuNP (blue trace), Tf-AuNP- 1 (black trace) and pPEGMA-Tf-AuNP-
1 (red trace); b) pMPC-AuNP (blue trace), Tf-AuNP- 2 (black trace) and pPEGMA-Tf-
AuNP-2 (red trace); c) pMPC-AuNP (blue trace), Tf-AuNP- 3 (black trace) and 
pPEGMA-Tf-AuNP-3 (red trace). 
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Figure S5 – Uptake of Tf-Alexa488 at 33°C and 41°C in HeLa cells. 
HeLa cells were pulsed with 10nM Tf-A488 for 2hrs in serum free medium containing 0.1% 
BSA before washing and imaging. Uptake represents >100 cells from 10 individual images, 
error bars represent inter-image standard deviation. 
 
 
Figure S6: Non false-colored images from Figure 3 to show effect of temperature-on the 
endocytosis of AuNPs and conjugates in HeLa cells evaluated by confocal microscopy. Images 
(a-c) and (g-i) show Tf-AuNP-1, -2, -3 at 33 °C and 41 °C, respectively, while images (d-f) 
and (j-l) show corresponding polymer-coated particles pPEGMA-Tf-AuNP-1, -2, -3 across the 
same temperature ranges. 
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Figure S7: Non false-colored images from Figure 5 to show competition of Tf-AuNP-3 and 
pPEGMA-Tf-AuNP-3 with excess Tf. HeLa cells were incubated with either Tf-AuNP-3 or 
pPEGMA-Tf-AuNP-3 in the presence or absence of 625 nM Tf for 2 h in serum free medium 
containing 0.1% BSA at 41°C before washing and imaging. 
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Table S1 –Sizes of nanoparticles by light scattering analysis. The most abundant diameter 
given (i.e. size at peak height in the number distribution ± 3 nm), with most significant sub-
population in brackets. 
Nanoparticle Diameter/ nm, 33 °C Diameter/ nm, 37 °C Diameter/ nm, 41 °C 
Tf-AuNP-1 48  51 342 (60) 
Tf-AuNP-2 50 50 60 
Tf-AuNP-3 49 50, (80) 530 (80) 
pPEGMA-Tf-AuNP-1 55 58, (91) 460 (80) 
pPEGMA-Tf-AuNP-2 57 61, (104) 700 (70) 
pPEGMA-Tf-AuNP-3 59 56 63 (450) 
 
Table S2 – Zeta potentials of nanoparticle  
Nanoparticle ζ / mV, 33 °C ζ / mV, 37 °C ζ / mV, 41 °C 
Tf-AuNP-1 -8.6 ± 1.7 -15.2 ± 4.3 -13.1 ± 1.7 
Tf-AuNP-2 -7.8  ± 0.4 -7.0 ± 1.4 -18 ± 2.4 
Tf-AuNP-3 -6.0 ± 0.3 -17.6 ± 1.2 -18.5 ± 0.1 
pPEGMA-Tf-AuNP-1 -6.1 ± 0.2 -13.8 ± 3.2 -19 ± 0.4 
pPEGMA-Tf-AuNP-2 -5.9 ±  0.3 -18.0 ± 3.8 -17.4 ± 0.8 
pPEGMA-Tf-AuNP-3 -7.9 ± 1.5 -9.0 ± 1.5 -11.3 ± 0.5 
 
Table S3 
Polymer mM thiol a mM thiol (theor) b 
pPEGMAdisulfide  0.007 2.39 
pPEGMA-SH  2.3 1.64 
pPEGMA-DBCO  0.06 0.98 
Ellman’s assay for disulfide, reduced and modified polymer solutions. a) Free thiol 
concentration measured by Ellman’s assay. b) Theoretical concentration of free thiol in solution 
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if polymers were fully reduced and non-modified. Polymer concentrations were calculated 
from Mn GPC.   
 
Table S4. Transferrin AuNP - conjugation. Tf degree of conjugation and particle recovery. 
ample Conditions 
TF grafting 
(no. TF/AuNP) 
Concentration 
(AuNP/mL) 
% AuNP 
recovery 
Tf-AuNP-1 2 eq. Tf/AuNP 0.7 1.33 x 1014 99.5% 
Tf-AuNP-2 4 eq. Tf/AuNP 1.3 1.23 x 1014 92.1% 
Tf-AuNP-3 8 eq. Tf/AuNP 3.0 1.27 x 1014 94.9% 
 
 
